BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
25 results:

  • 1. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis.
    Sahraoui G; Rahoui N; Driss M; Mrad K
    Int Rev Cell Mol Biol; 2024; 384():47-61. PubMed ID: 38637099
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparing p53 expression and genome-wide transcriptome profiling to Comet assay in lymphocytes from melanoma patients and healthy controls.
    Najafzadeh M; Naeem P; Ghaderi N; Jafarinejad S; Karimi Z; Ghaderi M; Akhbari P; Ghaderi R; Farsi P; Wright A; Anderson D
    Sci Rep; 2023 Nov; 13(1):18858. PubMed ID: 37914759
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcriptomic characterization revealed that METTL7A inhibits melanoma progression via the p53 signaling pathway and immunomodulatory pathway.
    Zhang D; Zou T; Liu Q; Chen J; Xiao M; Zheng A; Zhang Z; Du F; Dai Y; Xiang S; Wu X; Li M; Chen Y; Zhao Y; Shen J; Chen G; Xiao Z
    PeerJ; 2023; 11():e15799. PubMed ID: 37547717
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CRISPR/dCas9-KRAB-Mediated Suppression of
    Roy Choudhury S; Heflin B; Taylor E; Koss B; Avaritt NL; Tackett AJ
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899866
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A nomogram combining clinical factors and biomarkers for predicting the recurrence of high-risk cutaneous squamous cell carcinoma.
    Oh Y; Zheng Z; Kim KY; Xu X; Pei M; Oh B; Kim SK; Chung KY; Roh MR
    BMC Cancer; 2022 Nov; 22(1):1126. PubMed ID: 36324094
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022.
    Gauci ML; Aristei C; Becker JC; Blom A; Bataille V; Dreno B; Del Marmol V; Forsea AM; Fargnoli MC; Grob JJ; Gomes F; Hauschild A; Hoeller C; Harwood C; Kelleners-Smeets N; Kaufmann R; Lallas A; Malvehy J; Moreno-Ramirez D; Peris K; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; van Akkooi ACJ; Lorigan P; Garbe C; Lebbé C;
    Eur J Cancer; 2022 Aug; 171():203-231. PubMed ID: 35732101
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.
    Stachyra K; Dudzisz-Śledź M; Bylina E; Szumera-Ciećkiewicz A; Spałek MJ; Bartnik E; Rutkowski P; Czarnecka AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208339
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site.
    Zarei S; Voss JS; Jin L; Jenkins SM; Bryce AH; Erickson LA; Bell DA; Kipp BR; Flotte TJ
    Int J Gynecol Pathol; 2020 Nov; 39(6):587-594. PubMed ID: 31567539
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
    Nye A; Collins JD; Porter CL; Montes de Oca M; George K; Stafford CG; Schammel CMG; Horton S; Trocha SD
    Melanoma Res; 2018 Dec; 28(6):555-561. PubMed ID: 30179987
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Melanoma of the Vagina: Case Report and Systematic Review of the Literature.
    Rapi V; Dogan A; Schultheis B; Hartmann F; Rezniczek GA; Tempfer CB
    Anticancer Res; 2017 Dec; 37(12):6911-6920. PubMed ID: 29187473
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. p53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions.
    Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M
    Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical and Pathological Significance of ER Stress Marker (BiP/GRP78 and PERK) Expression in Malignant Melanoma.
    Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
    Pathol Oncol Res; 2017 Jan; 23(1):111-116. PubMed ID: 27502501
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
    Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
    Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. microRNA portraits in human vulvar carcinoma.
    de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma.
    Ishitsuka Y; Kawachi Y; Taguchi S; Maruyama H; Nakamura Y; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
    Exp Dermatol; 2013 May; 22(5):318-22. PubMed ID: 23489647
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The evolution of S100B inhibitors for the treatment of malignant melanoma.
    Hartman KG; McKnight LE; Liriano MA; Weber DJ
    Future Med Chem; 2013 Jan; 5(1):97-109. PubMed ID: 23256816
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability.
    Pandey A; Kurup A; Shrivastava A; Radhi S; Nguyen DD; Arentz C; D'Chuna N; Hardwick F; D'Souza MJ; Jenkins M; Grizzi F; Kast WM; Cobos E; Rahman R; Chiriva-Internati M; Chiaramonte R; Platonova N
    Int Rev Immunol; 2012 Oct; 31(5):302-20. PubMed ID: 23083343
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.